|
Originally published In Press as doi:10.1074/jbc.M209572200 on November 4, 2002
J. Biol. Chem., Vol. 278, Issue 4, 2758-2766, January 24, 2003
Post-activation Turn-off of NF- B-dependent
Transcription Is Regulated by Acetylation of p65*
Rosemary
Kiernan §,
Vanessa
Brès ,
Raymond W. M.
Ng¶,
Marie-Pierre
Coudart ,
Selma
El Messaoudi **,
Claude
Sardet ,
Dong-Yan
Jin¶ ,
Stephane
Emiliani§§, and
Monsef
Benkirane ¶¶
From the Laboratoire de Virologie Moléculaire,
Institut de Génétique Humaine, Institut de
Génétique Moléculaire, Montpellier 34296, France, the
§§ Departement des Maladies Infectieuses,
Institut Cochin, Paris 75014, France, and the ¶ Department of
Biochemistry, The University of Hong Kong, Hong Kong, China
NF- B represents a family of eukaryotic
transcription factors participating in the regulation of various
cellular genes involved in the immediate early processes of immune,
acute-phase, and inflammatory responses. Cellular localization and
consequently the transcriptional activity of NF- B is tightly
regulated by its partner I B . Here, we show that the p65 subunit
of NF- B is acetylated by both p300 and PCAF on lysines 122 and 123. Both HDAC2 and HDAC3 interact with p65, although only HDAC3 was able to
deacetylate p65. Acetylation of p65 reduces its ability to bind
B-DNA. Finally, acetylation of p65 facilitated its removal from
DNA and consequently its I B -mediated export from the nucleus.
We propose that acetylation of p65 plays a key role in
I B -mediated attenuation of NF- B transcriptional activity
which is an important process that restores the latent state in
post-induced cells.
*
This work was supported in part by grants from the Agence
Nationale de Recherche sur le SIDA, Human Frontier Science
Program, Minister de la Recherche (ACI) (to M. B.), ARC (to S. E.),
Human Frontier Science Program (to C. S.), and Grants HK-RGC and
HKU (to D.-Y. J.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by an ANRS fellowship.
**
Supported by a Ligue National Contre le Cancer fellowship.

A Leukemia and Lymphoma Society Scholar.
¶¶
To whom correspondence should be addressed: Laboratoire
de Virologie Moléculaire, Institut de Génétique
Humaine, 141 rue de la Cardonille, Montpellier 34396, France. Tel.:
33-4-99-61-99-32; Fax: 33-4-99-61-99-01; E-mail:
bmonsef@igh.cnrs.fr.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Chiechio, M. Zammataro, M. E. Morales, C. L. Busceti, F. Drago, R. W. Gereau IV, A. Copani, and F. Nicoletti
Epigenetic Modulation of mGlu2 Receptors by Histone Deacetylase Inhibitors in the Treatment of Inflammatory Pain
Mol. Pharmacol.,
May 1, 2009;
75(5):
1014 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Mao, N. Gluck, D. Li, G. N. Maine, H. Li, I. W. Zaidi, A. Repaka, M. W. Mayo, and E. Burstein
GCN5 is a required cofactor for a ubiquitin ligase that targets NF-{kappa}B/RelA
Genes & Dev.,
April 1, 2009;
23(7):
849 - 861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Huang, X.-D. Yang, M.-M. Zhou, K. Ozato, and L.-F. Chen
Brd4 Coactivates Transcriptional Activation of NF-{kappa}B via Specific Binding to Acetylated RelA
Mol. Cell. Biol.,
March 1, 2009;
29(5):
1375 - 1387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
Eur. Heart J.,
February 1, 2009;
30(3):
266 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-C. Choi, M. G. Jung, Y.-H. Lee, J. C. Yoon, S. H. Kwon, H.-B. Kang, M.-J. Kim, J.-H. Cha, Y. J. Kim, W. J. Jun, et al.
Epigallocatechin-3-Gallate, a Histone Acetyltransferase Inhibitor, Inhibits EBV-Induced B Lymphocyte Transformation via Suppression of RelA Acetylation
Cancer Res.,
January 15, 2009;
69(2):
583 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Kingeter and B. C. Schaefer
Loss of Protein Kinase C{theta}, Bcl10, or Malt1 Selectively Impairs Proliferation and NF-{kappa}B Activation in the CD4+ T Cell Subset
J. Immunol.,
November 1, 2008;
181(9):
6244 - 6254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Makki, T. Heinzel, and C. Englert
TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
Nucleic Acids Res.,
July 1, 2008;
36(12):
4067 - 4078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sun, R. D. Ramnath, L. Zhi, R. Tamizhselvi, and M. Bhatia
Substance P enhances NF-{kappa}B transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways
Am J Physiol Cell Physiol,
June 1, 2008;
294(6):
C1586 - C1596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Glauben, A Batra, T Stroh, U Erben, I Fedke, H A Lehr, F Leoni, P Mascagni, C A Dinarello, M Zeitz, et al.
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice
Gut,
May 1, 2008;
57(5):
613 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sabo, M. Lusic, A. Cereseto, and M. Giacca
Acetylation of Conserved Lysines in the Catalytic Core of Cyclin-Dependent Kinase 9 Inhibits Kinase Activity and Regulates Transcription
Mol. Cell. Biol.,
April 1, 2008;
28(7):
2201 - 2212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Buerki, K. M. Rothgiesser, T. Valovka, H. R. Owen, H. Rehrauer, M. Fey, W. S. Lane, and M. O. Hottiger
Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65
Nucleic Acids Res.,
March 1, 2008;
36(5):
1665 - 1680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Asano, J. Czuwara, and M. Trojanowska
Transforming Growth Factor- Regulates DNA Binding Activity of Transcription Factor Fli1 by p300/CREB-binding Protein-associated Factor-dependent Acetylation
J. Biol. Chem.,
November 30, 2007;
282(48):
34672 - 34683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Saha, M. Jana, and K. Pahan
MAPK p38 Regulates Transcriptional Activity of NF-{kappa}B in Primary Human Astrocytes via Acetylation of p65
J. Immunol.,
November 15, 2007;
179(10):
7101 - 7109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, S. A. Mahmud, P. B. Bitterman, Y. Huo, and A. Slungaard
Histone Deacetylase Inhibitors Suppress TF-{kappa}B-dependent Agonist-driven Tissue Factor Expression in Endothelial Cells and Monocytes
J. Biol. Chem.,
September 28, 2007;
282(39):
28408 - 28418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Liu, Y. Tsuruta, Z. Gao, Y.-J. Park, and E. Abraham
Variant IL-1 Receptor-Associated Kinase-1 Mediates Increased NF-{kappa}B Activity
J. Immunol.,
September 15, 2007;
179(6):
4125 - 4134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Gazzar, B. K. Yoza, J. Y.-Q. Hu, S. L. Cousart, and C. E. McCall
Epigenetic Silencing of Tumor Necrosis Factor {alpha} during Endotoxin Tolerance
J. Biol. Chem.,
September 14, 2007;
282(37):
26857 - 26864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Neumann and M. Naumann
Beyond I{kappa}Bs: alternative regulation of NF-{kappa}B activity
FASEB J,
September 1, 2007;
21(11):
2642 - 2654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gloire, J. Horion, N. El Mjiyad, F. Bex, A. Chariot, E. Dejardin, and J. Piette
Promoter-dependent Effect of IKK{alpha} on NF-{kappa}B/p65 DNA Binding
J. Biol. Chem.,
July 20, 2007;
282(29):
21308 - 21318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yan, Z. Gao, G. Yu, Q. He, J. Weng, and J. Ye
Nuclear Corepressor Is Required for Inhibition of Phosphoenolpyruvate Carboxykinase Expression by Tumor Necrosis Factor-{alpha}
Mol. Endocrinol.,
July 1, 2007;
21(7):
1630 - 1641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. d. Paz, S. Simeonidis, C. Leo, D. W. Rose, and T. Collins
Regulation of NF-{kappa}B-dependent Gene Expression by the POU Domain Transcription Factor Oct-1
J. Biol. Chem.,
March 16, 2007;
282(11):
8424 - 8434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, P. W. Smith, and D. R. Jones
Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis
Mol. Cell. Biol.,
December 1, 2006;
26(23):
8683 - 8696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, C. E. Denlinger, B. K. Rundall, P. W. Smith, and D. R. Jones
Suberoylanilide Hydroxamic Acid Induces Akt-mediated Phosphorylation of p300, Which Promotes Acetylation and Transcriptional Activation of RelA/p65
J. Biol. Chem.,
October 20, 2006;
281(42):
31359 - 31368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. M. Schaaf, L. Willetts, B. P. Hayes, B. Maschera, E. Stylianou, and S. N. Farrow
The Relationship between Intranuclear Mobility of the NF-{kappa}B Subunit p65 and Its DNA Binding Affinity
J. Biol. Chem.,
August 4, 2006;
281(31):
22409 - 22420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Y. Park, X. Wang, N. Hu, T. V. Pedchenko, T. S. Blackwell, and J. W. Christman
NIK Is Involved in Nucleosomal Regulation by Enhancing Histone H3 Phosphorylation by IKK{alpha}
J. Biol. Chem.,
July 7, 2006;
281(27):
18684 - 18690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Kim, E. M. Woo, Y. T. E. Chong, D. R. Homenko, and W. L. Kraus
Acetylation of Estrogen Receptor {alpha} by p300 at Lysines 266 and 268 Enhances the Deoxyribonucleic Acid Binding and Transactivation Activities of the Receptor
Mol. Endocrinol.,
July 1, 2006;
20(7):
1479 - 1493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Imre, V. Gekeler, A. Leja, T. Beckers, and M. Boehm
Histone Deacetylase Inhibitors Suppress the Inducibility of Nuclear Factor-{kappa}B by Tumor Necrosis Factor-{alpha} Receptor-1 Down-regulation.
Cancer Res.,
May 15, 2006;
66(10):
5409 - 5418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Gao, Q. He, B. Peng, P. J. Chiao, and J. Ye
Regulation of Nuclear Translocation of HDAC3 by I{kappa}B{alpha} Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor {gamma} Function
J. Biol. Chem.,
February 17, 2006;
281(7):
4540 - 4547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. H. Kramer, D. Baus, S. K. Knauer, S. Stein, E. Jager, R. H. Stauber, M. Grez, E. Pfitzner, and T. Heinzel
Acetylation of Stat1 modulates NF-{kappa}B activity.
Genes & Dev.,
February 15, 2006;
20(4):
473 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Chang and S. Miyamoto
Nuclear Factor-{kappa}B Dimer Exchange Promotes a p21waf1/cip1 Superinduction Response in Human T Leukemic Cells
Mol. Cancer Res.,
February 1, 2006;
4(2):
101 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Hoberg, A. E. Popko, C. S. Ramsey, and M. W. Mayo
I{kappa}B Kinase {alpha}-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300
Mol. Cell. Biol.,
January 15, 2006;
26(2):
457 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cui, J. Z. Ke, Q. Zhang, H.-Z. Ke, C. Chalouni, and A. Vignery
The intracellular domain of CD44 promotes the fusion of macrophages
Blood,
January 15, 2006;
107(2):
796 - 805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal
Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of I{kappa}B{alpha} Kinase and Akt Activation
Mol. Pharmacol.,
January 1, 2006;
69(1):
195 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-F. Chen, S. A. Williams, Y. Mu, H. Nakano, J. M. Duerr, L. Buckbinder, and W. C. Greene
NF-{kappa}B RelA Phosphorylation Regulates RelA Acetylation
Mol. Cell. Biol.,
September 15, 2005;
25(18):
7966 - 7975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dai, M. Rahmani, P. Dent, and S. Grant
Blockade of Histone Deacetylase Inhibitor-Induced RelA/p65 Acetylation and NF-{kappa}B Activation Potentiates Apoptosis in Leukemia Cells through a Process Mediated by Oxidative Damage, XIAP Downregulation, and c-Jun N-Terminal Kinase 1 Activation
Mol. Cell. Biol.,
July 1, 2005;
25(13):
5429 - 5444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Grasberger, U. Ringkananont, P. LeFrancois, M. Abramowicz, G. Vassart, and S. Refetoff
Thyroid Transcription Factor 1 Rescues PAX8/p300 Synergism Impaired by a Natural PAX8 Paired Domain Mutation with Dominant Negative Activity
Mol. Endocrinol.,
July 1, 2005;
19(7):
1779 - 1791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Gao, P. Chiao, X. Zhang, X. Zhang, M. A. Lazar, E. Seto, H. A. Young, and J. Ye
Coactivators and Corepressors of NF-{kappa}B in I{kappa}B{alpha} Gene Promoter
J. Biol. Chem.,
June 3, 2005;
280(22):
21091 - 21098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Ho, K. M. Dickson, and P. A. Barker
Nuclear Factor-{kappa}B Induced by Doxorubicin Is Deficient in Phosphorylation and Acetylation and Represses Nuclear Factor-{kappa}B-Dependent Transcription in Cancer Cells
Cancer Res.,
May 15, 2005;
65(10):
4273 - 4281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Andresen, V L Jorgensen, A Perner, A Hansen, J Eugen-Olsen, and J Rask-Madsen
Activation of nuclear factor {kappa}B in colonic mucosa from patients with collagenous and ulcerative colitis
Gut,
April 1, 2005;
54(4):
503 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koyanagi, M. Hijikata, K. Watashi, O. Masui, and K. Shimotohno
Centrosomal P4.1-associated Protein Is a New Member of Transcriptional Coactivators for Nuclear Factor-{kappa}B
J. Biol. Chem.,
April 1, 2005;
280(13):
12430 - 12437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Edelstein, A. Pan, and T. Collins
Chromatin Modification and the Endothelial-specific Activation of the E-selectin Gene
J. Biol. Chem.,
March 25, 2005;
280(12):
11192 - 11202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-J. Jeong, C. A. Pise-Masison, M. F. Radonovich, H. U. Park, and J. N. Brady
A Novel NF-{kappa}B Pathway Involving IKK{beta} and p65/RelA Ser-536 Phosphorylation Results in p53 Inhibition in the Absence of NF-{kappa}B Transcriptional Activity
J. Biol. Chem.,
March 18, 2005;
280(11):
10326 - 10332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Duan, C. A. Heckman, and L. M. Boxer
Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas
Mol. Cell. Biol.,
March 1, 2005;
25(5):
1608 - 1619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Burkhart, P. B. Hebbar, K. W. Trotter, and T. K. Archer
Chromatin-dependent E1A Activity Modulates NF-{kappa}B RelA-mediated Repression of Glucocorticoid Receptor-dependent Transcription
J. Biol. Chem.,
February 25, 2005;
280(8):
6349 - 6358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hu and N. H. Colburn
Histone Deacetylase Inhibition Down-Regulates Cyclin D1 Transcription by Inhibiting Nuclear Factor-{kappa}B/p65 DNA Binding
Mol. Cancer Res.,
February 1, 2005;
3(2):
100 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Anrather, G. Racchumi, and C. Iadecola
cis-Acting Element-specific Transcriptional Activity of Differentially Phosphorylated Nuclear Factor-{kappa}B
J. Biol. Chem.,
January 7, 2005;
280(1):
244 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Labalette, C.-A. Renard, C. Neuveut, M.-A. Buendia, and Y. Wei
Interaction and Functional Cooperation between the LIM Protein FHL2, CBP/p300, and {beta}-Catenin
Mol. Cell. Biol.,
December 15, 2004;
24(24):
10689 - 10702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hu, H. Nakano, H. Sakurai, and N. H. Colburn
Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-{kappa}B activation and transformation in resistant JB6 cells
Carcinogenesis,
October 1, 2004;
25(10):
1991 - 2003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Hayden and S. Ghosh
Signaling to NF-{kappa}B
Genes & Dev.,
September 15, 2004;
18(18):
2195 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Veal, C.-L. Hsieh, S. Xiong, J. M. Mato, S. Lu, and H. Tsukamoto
Inhibition of lipopolysaccharide-stimulated TNF-{alpha} promoter activity by S-adenosylmethionine and 5'-methylthioadenosine
Am J Physiol Gastrointest Liver Physiol,
August 1, 2004;
287(2):
G352 - G362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Yeh, C.-H. Lin, and P.-W. Gean
Acetylation of Nuclear Factor-{kappa}B in Rat Amygdala Improves Long-Term but not Short-Term Retention of Fear Memory
Mol. Pharmacol.,
May 1, 2004;
65(5):
1286 - 1292.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Levy, Y. Wei, C. Labalette, Y. Wu, C.-A. Renard, M. A. Buendia, and C. Neuveut
Acetylation of {beta}-Catenin by p300 Regulates {beta}-Catenin-Tcf4 Interaction
Mol. Cell. Biol.,
April 15, 2004;
24(8):
3404 - 3414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Adam, V. Quivy, F. Bex, A. Chariot, Y. Collette, C. Vanhulle, S. Schoonbroodt, V. Goffin, T. L.-A. Nguyen, G. Gloire, et al.
Potentiation of Tumor Necrosis Factor-Induced NF-{kappa}B Activation by Deacetylase Inhibitors Is Associated with a Delayed Cytoplasmic Reappearance of I{kappa}B{alpha}
Mol. Cell. Biol.,
September 1, 2003;
23(17):
6200 - 6209.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|